Stockscreener 앱 받기
0.46
7.07%
-0.035
시간 외 거래:
.46
전일 마감가:
$0.495
열려 있는:
$0.44
하루 거래량:
42,955
Relative Volume:
0.48
시가총액:
$816.45K
수익:
$600.00K
순이익/손실:
$-32.95M
주가수익비율:
-0.0264
EPS:
-17.4085
순현금흐름:
$-34.11M
1주 성능:
-65.67%
1개월 성능:
-69.13%
6개월 성능:
-92.76%
1년 성능:
-94.21%
1일 변동 폭
$0.44
$0.51
1주일 범위
$0.44
$1.34
52주 변동 폭
$0.44
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Compare LYRA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
0.46 | 878.57K | 600.00K | -32.95M | -34.11M | -17.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-05-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | 재개 | BTIG Research | Buy |
| 2023-08-31 | 개시 | H.C. Wainwright | Buy |
| 2022-05-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-26 | 개시 | BTIG Research | Buy |
| 2020-05-26 | 개시 | BofA/Merrill | Buy |
| 2020-05-26 | 개시 | Jefferies | Buy |
| 2020-05-26 | 개시 | William Blair | Outperform |
모두보기
Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스
Non-operating income (total) of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Lyra Therapeutics, Inc.(OTCPK: LYRA) dropped from S&P TMI Index - marketscreener.com
Return on equity % of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Debt to assets ratio of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Price to earnings ratio of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Lyra Therapeutics, Inc. Income Statement – OTC:LYRA - TradingView
Lyra Therapeutics, Inc. Revenue Breakdown – OTC:LYRA - TradingView
Lyra Therapeutics, Inc. Earnings and Revenue – OTC:LYRA - TradingView
LYRA Stock Price and Chart — OTC:LYRA - TradingView
LYRA SEC FilingsLyra Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lyra Therapeutics Inc withdraws appeal of Nasdaq delisting determinationSEC filing - marketscreener.com
Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting - TipRanks
Lyra Therapeutics Received Notice of Delisting - TradingView
Lyra Therapeutics (NASDAQ: LYRA) withdraws appeal, faces Nasdaq delisting - Stock Titan
LYRA Stock Price, Quote & Chart | LYRA THERAPEUTICS INC (NASDAQ:LYRA) - ChartMill
According to the latest disclosure from the U.S. Securities and Exchange Commission, trading of Lyra Therapeutics Inc (stock code: LYRA) shares will be officially suspended at the market open on March 17, 2026. - Bitget
Lyra Therapeutics, Inc.(OTCPK: LYRA) dropped from NASDAQ Composite Index - marketscreener.com
Hedge Fund Moves: Can Lyra Therapeutics Inc outperform under higher oil prices2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
BBNX,LYRA Options - Finviz
BBNX,LYRA Volatility & Greeks - Finviz
Lyra Therapeutics Inc expected to post a loss of $7.14 a shareEarnings Preview - TradingView
Does Lyra Therapeutics Inc. stock trade at a discount to peersGap Down & Real-Time Buy Zone Alerts - Naître et grandir
Growth Review: Will Lyra Therapeutics Inc be affected by tariffsJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
LYRA Technical Analysis & ETF Price Forecast - Intellectia AI
Lyra Therapeutics to Present at Upcoming Investor Conferences - PR Newswire
Lyra Therapeutics receives default notice for unpaid rent as wind-down continues - Investing.com India
LYRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LYRA Technical Analysis & Stock Price Forecast - Intellectia AI
Lyra Therapeutics receives default notice for unpaid rent as wind-down continues By Investing.com - Investing.com South Africa
LYRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lyra Therapeutics (LYRA) hit with sublease default as it winds down - Stock Titan
Short Covering: What are the risks of holding Lyra Therapeutics IncWeekly Market Outlook & AI Powered Market Entry Ideas - baoquankhu1.vn
LYRA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Lyra Therapeutics Inc be affected by tariffs2025 Institutional Moves & Daily Market Momentum Tracking - baoquankhu1.vn
Pullback Watch: Is Lyra Therapeutics Inc stock a good pick for beginnersJuly 2025 Earnings & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Stock Report: What is Lyra Therapeutics Incs P E ratio telling usWeekly Trade Analysis & Verified Short-Term Trading Plans - baoquankhu1.vn
Quarterly Risk: Will Lyra Therapeutics Inc be affected by tariffs2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Can Lyra Therapeutics Inc. outperform under higher oil pricesQuarterly Portfolio Report & Safe Capital Investment Plans - mfd.ru
What are the analyst revisions for Lyra Therapeutics Inc.Is BBAR stock a good investment in YEARTrade Entry Report & Daily Profit Focused Stock Screening - mfd.ru
Is Lyra Therapeutics Inc. stock vulnerable to regulatory risksWeekly Trading Summary & Consistent Growth Stock Picks - mfd.ru
Analyst Upgrade: How much upside does Lyra Therapeutics Inc haveJuly 2025 Short Interest & Weekly High Return Stock Opportunities - baoquankhu1.vn
Lyra Therapeutics Faces Nasdaq Delisting Battle After Clinical Setback - AD HOC NEWS
Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell - The Globe and Mail
Lyra Therapeutics (LYRA) Faces Nasdaq Delisting - GuruFocus
Lyra Therapeutics Faces Nasdaq Delisting Over Shell Company Concerns, Capital Shortfall - marketscreener.com
Nasdaq plans to delist Lyra Therapeutics (LYRA) after shell status finding - Stock Titan
What is the dividend yield of Lyra Therapeutics IncMarket Risk Analysis & Risk Managed Investment Strategies - baoquankhu1.vn
Aug Sectors: Can Lyra Therapeutics Inc grow without external funding2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn
Why hedge funds are buying Lyra Therapeutics Inc. stockJuly 2025 Drop Watch & Safe Capital Growth Trade Ideas - mfd.ru
What is the dividend yield of Lyra Therapeutics Inc.July 2025 EndofMonth & Verified Swing Trading Watchlist - mfd.ru
Should I buy Lyra Therapeutics Inc. stock nowWeekly Profit Summary & Weekly Setup with High ROI Potential - mfd.ru
Lyra Therapeutics Inc (LYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):